An update to the previously published multispeciality guide for the management of diabetes, cardiorenal and metabolic diseases will be issued later this year with sweeping updates based on the latest data, a speaker reported. Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, co-chair of Heart in Diabetes and medical director and principal investigator of the Metabolic Institute of America in